This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Euro Managanese Inc
5/21/2024
Good day, everyone. Welcome to Euromanganese's second quarter 2024 conference call. We still have some people joining, so we'll give it about 30 seconds or so before we get started. Please note this webcast is being recorded and a replay will be available on our website. You can download the slides that we used today from the website as well. And after the presentation, we'll have a question and answer period. If you'd like to ask a question, please use the Q&A function at the bottom of your screen. You can enter a question at any point during the presentation and we'll cover it during the Q&A period. But we also welcome questions post the call, so please feel free to reach out to Matt, Martina, or myself. Before we begin, note that this presentation involves forward-looking statements. Please refer to our cautionary statements here and the risk factors in our annual information form. Our second quarter financial statements and management discussion and analysis for the three and six month periods ending March 31st, 2024 were filed on May 15th, 2024. All of these materials are available on our website, CDAR Plus and the ASX. Over to you, Matt.
Good morning and good afternoon to everyone. Thank you for joining us to review developments during Euromangani's second fiscal quarter. Joining me on the call today is Martina Blahova, Chief Financial Officer. I'll pass over to Martina in a moment to go through financial highlights for the quarter and the company's financial position. Then we'll run through key developments during the quarter and how we are performing against our key 2024 catalysts. We'll wrap up with a question and answer session. Over to you, Martina.
Thank you, Matt. Just a reminder that our fiscal year end is September 30th, so our Q2 references the period January 2024 through March 2024. We also report in Canadian dollars. I will briefly comment on our cash possession at the end of the quarter. We started the quarter with 24.3 million in cash. 0.4 million was spent to advance the commissioning of the demonstration plant, which is nearing completion. 1.3 million was spent on operational expenditures, which included the advancement of Kvalitice permitting and other corporate costs. These expenditures are net of 0.8 million of cash generated in operating activities by EP Chvaletice, a specialty steel fabrication product company acquired at the end of last quarter, as its key asset is the land it owns, which is intended for the project's processing plant. Interest on the convertible loan was 0.3 million. We also made land acquisition and lease payments of 2.2 million. We closed the quarter with 20.1 million in the bank. Our cash balance is expected to provide sufficient funding to complete project permitting, demonstration plant commissioning, and ongoing operations, as well as continuing to make lease and option payments for land parcels required for the project. This cash is also expected to enable us to continue with the initial feed base of the EPCM contract and certain site preparation works, as well as fund general and administration expenses. I will now turn it back to Matt.
You're reading a preview of the EUMNF Q2 2024 earnings call.
Free account.